Skip to main content
EJNMMI Research
Fig. 2 | EJNMMI Research

Fig. 2

From: Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors

Fig. 2

The intratumoral activity distribution of 211At-A11 in s.c. PSCA-PC3 macrotumors at 3 hpi (a) as studied by alpha camera imaging [22]. The color coded LUT is normalized so that 1.0 represent the mean activity for the whole tumor section. White scale bar indicate 1000 μm. Consecutive H&E-stained section (b). LUT look-up-table; H&E Hematoxylin and eosin

Back to article page